Shares of Krishna Institute of Medical Sciences (KIMS) traded nearly 2 percent higher on the NSE on September 12. At the open, the shares were trading at Rs 2,176.25, a day after it made a Rs 20-crore investment by further acquiring an equity stake of 13.24 percent in Kondapur Healthcare Limited.
The Hyderabad-based Krishna Institute of Medical Sciences (KIMS), said in a regulatory filing that its stake in Kondapur Healthcare stands at 19.86 percent. Kondapur Healthcare is yet to commence its operations.
In an August 2023 report, analysts at Edelweiss said that they continue to remain positive on KIMS-based on its healthy expansion plan, anticipated increase in operating beds, better occupancy, and higher operating margin, with a focus on operational efficiency. For the period of FY2023-25, they expect the revenue to grow 25 percent with the addition of approximately 726 occupied beds and assuming an expansion of 6 percent stake in ARPOB.
For the quarter ended June 2023, the hospital chain with presence across Telangana, Maharashtra and Andhra Pradesh reported. For Q1FY2024, according to an investor presentation, the total bed capacity, across locations, increased to 3,975 from 3,666 in the last fiscal. KIMS is a multi-speciality hospital offering services in segments such as mother and child, organ transplant, gastric sciences, oncology, renal sciences, oncology amongst other. According to the management, the hospital chain is looking to expand its footprint in Karnataka, Maharashtra, Tamil Nadu and Odisha. Moneycontrol